Stay updated on Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page
- Check6 days agoChange DetectedNew revision entry v3.5.3 was added to the revision history, replacing the prior v3.5.2. This represents an update to the page’s revision record, reflecting an updated version of the page metadata.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision history now shows an addition of v3.5.2 and a deletion of v3.5.0.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedA new revision entry v3.5.0 was added to the record history. The previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded revision label v3.4.3 and removed revision label v3.4.2 from the record history.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded a new revision entry, Revision: v3.4.2, to the study record history. Removed older administrative notices including the government funding lapse alert and the Revision: v3.4.1 entry.SummaryDifference0.6%

- Check92 days agoChange DetectedAdded a government funding notice in the header and updated the revision tag to v3.4.1; the previous tag v3.4.0 was removed.SummaryDifference0.6%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.